Do you provide OEM/private labeling services?

Our factory (Hangzhou Testsea, ISO 13485 & CE certified) supports customized packaging, branding, and insert design, allowing distributors to build local brand presence.

Plasma)

Name: Herpes Simplex Virus I/II IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma)
Brand: HangZhou Testsea biotechnology Co., Ltd.
SKU: 2316786805

Zhejiang, ChinaHangZhou Testsea biotechnology Co., Ltd.

US$0.10

2,000-9,999 Pieces

US$0.09

10,000-99,999 Pieces

US$0.08

100,000+ Pieces

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Type

Rapid Diagnostic Test

Format

Cassette

Specimen

Whole Blood/Serum/Plasma

Sensitity

97.6%

Specificity

98.1%

Box Specification

25 or 40 Tests/Box

Weight/Carton

20.00kg

Certificate

CE Certificate & ISO 13485

Shelf Life

24 Months

Test Time

10 Minutes

Usage

Professional Use or Home Use

Instrument Classification

Class III

Quality Certification

Transport Package

66*36*56.5cm

Specification

268*124*65mm

Trademark

Testsealabs

Origin

China

HS Code

3822190090

Production Capacity

3000000/Day

Key features

Dual IgG/IgM Differentiation: Detects acute and past HSV infections in one test, saving time and sample volume.

Clinically Validated Accuracy: 98.62% (IgM) and 98.07% (IgG) overall agreement, backed by 362 clinical samples.

15-Minute Rapid Results: Instrument-free visual readouts, ideal for point-of-care and high-throughput screening.

Works with whole blood serum or plasma

Company profile

HangZhou Testsea biotechnology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2022-04-08Nearest Port: Shanghai, Ningbo, ShenzhenAverage Response Time: ≤10.31h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryTestsea Biotechnology is identified as a China-based limited company in Hangzhou, with records describing it as both a trading company and manufacturer/factory. Its stated capabilities include in-vitro diagnostic, veterinary, rapid-test, reagent, and medical-machine products. The supplier reports ISO 9001 and GMP certification, more than 10 production lines, 50 R&D engineers, 50 quality-control staff, and exports to multiple global regions. It describes three technical platforms and sales coverage exceeding 100 countries and regions. However, the evidence does not establish after-sales performance, financial credibility, or product-customization capability. One record associates the supplier with a 2025 THC urine-test product and a Vietnamese buyer, but this is limited customer evidence and does not independently verify broader performance.

Supplier typeThe supplier is identified as a limited company headquartered in Hangzhou, China, and is described as both a trading company/manufacturer-factory. A separate record characterizes the company nature as a factory, supporting a manufacturing role alongside trading activity.

CertificationsThe supplier reports ISO 9001 and GMP certification under its management-system certifications. These are explicit certifications relevant to quality and manufacturing controls.

R&D capabilityThe supplier states that it develops core innovative raw-material technologies and has established immunological detection, molecular-biology detection, and protein core-sheet inspection platforms. The reported 50 R&D engineers and continuing R&D investment further support an established innovation function.

Production capacityThe supplier reports more than 10 production lines, 50 quality-control staff, a one-month off-peak lead time, and broad diagnostic-product offerings. It also reports 90% export sales and access to Shanghai, Ningbo, and Shenzhen ports, although the stated peak-season fulfillment time of 6–12 months indicates substantial seasonal capacity constraints.

Client casesThe supplier states that its products have been sold in more than 100 countries and regions. A separate record identifies a THC urine-test product and one associated Vietnamese buyer, but it does not provide verifiable case details such as order scale, duration, performance results, or references.

Product Q&A

Q:Can this test distinguish between HSV-1 and HSV-2 infections?

Yes. The test detects IgG and IgM antibodies to both HSV-1 and HSV-2 combined, but does not differentiate between the two types. For type-specific differentiation, additional molecular testing is recommended.

Q:What is the difference between the IgM and IgG results?

IgM positivity suggests a recent or primary infection, while IgG positivity indicates past or recurrent infection. Simultaneous presence may suggest reactivation or late stage primary infection aiding clinical staging.

Q:What sample types are compatible?

The test supports whole blood (fingerstick or venipuncture), serum, and plasma, offering flexible collection for various clinical settings, including remote outreach programs.

Q:How long does the test take?

Results are available in 15 minutes, with visual interpretation requiring no instrumentation ideal for emergency rooms, clinics, and field screening.

Q:Who is this test intended for?

It is designed for prenatal screening, STI clinics, immunocompromised patients, pre surgical evaluations, and epidemiological surveillance supporting broad public health applications.